[361]
Upper gastrointestinal cancer pathology reporting: a regional ...
From [jcp.bmjjournals.com] Last viewed: 13.07.2004
Cambridge-Munich Upper Gastrointestinal Cancer Workshop
Trinity College Cambridge
March 28
th
to 30
th
2004
Preliminary Programme
Sunday 28
th
March
Afternoon - Tour of colleges
Evening - Trinity College
Drinks reception
Guest lecture: Molecular imaging
Professor Kevin Brindle, Biochemistry Department, Cambridge
Informal buffet supper
Page 2
Monday 29
th
March
Introduction and aims of the workshop : Carlos Caldas and Heinz Hoefler
Morning session 1 – Genetic susceptibility to upper GI cancers
Caldas (Oncology, Cambridge)
Hereditary diffuse gastric cancer
Keller/Vogelsang (Pathology, Munich)
Familial gastric cancer
Pharoah (Oncology, Cambridge)
Low penetrance susceptibility genes -
Stomach Oesophageal Cancer ...
[362]
Flavopiridol Increases Sensitization to Gemcitabine in Human ...
[231,5 KB]
From [clincancerres.aacrjournals.org] Last viewed: 13.07.2004
Web Immagini Gruppi Directory News Novità!
Ricerca avanzata Preferenze
Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL
Web
La ricerca di - cache:vQNv61IlPDIJ:groups.eortc.be/radio/PANCREAS/form.pdf allintitle: gastrointestinal cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti:
- Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave.
...
[363]
Guidance on gastrointestinal surveillance for hereditary non ...
[210,3 KB]
From [gut.bmjjournals.com] Last viewed: 13.07.2004
Web Immagini Gruppi Directory News Novità!
Ricerca avanzata Preferenze
Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL
Web
La ricerca di - cache:vQNv61IlPDIJ:groups.eortc.be/radio/PANCREAS/form.pdf allintitle: gastrointestinal cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti:
- Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave.
...
[364]
Upper Gastrointestinal Cancer in a Population-based Screening ...
[20,9 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
SEPTEMBER 2003 |
Hem/Onc today
24
GASTROINTESTINAL CANCER DRUGS IN THE PIPELINE
Information for this chart was gathered from the Pharmaceutical Research and Manufacturers of America, corporate Web sites, meeting abstracts,
and the databases of H
EM
/O
NC
T
ODAY
. The publisher or editors do not assume responsibility for any errors or omissions.
Generic Product
Company
Indication
Phase
572016
Not yet available
GlaxoSmithKline
Colorectal cancer
Phase 2
ABT-510
Not yet available
Abbott Laboratories
Colorectal cancer
Phase 2 planned
ABX-EGF
Not yet available
Abgenix
Renal cancer
Phase 2
Adenoviral p53 (INGN 201)
Not yet available
Introgen Therapeutics
Esophageal squamous cell carcinoma
Phase 1/2
ALVAC-CEA/B7.1
Not yet available ...
[365]
Has Progress Been Made in Gastrointestinal Cancer Treatment?
[22,9 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
SEPTEMBER 2003 |
Hem/Onc today
24
GASTROINTESTINAL CANCER DRUGS IN THE PIPELINE
Information for this chart was gathered from the Pharmaceutical Research and Manufacturers of America, corporate Web sites, meeting abstracts,
and the databases of H
EM
/O
NC
T
ODAY
. The publisher or editors do not assume responsibility for any errors or omissions.
Generic Product
Company
Indication
Phase
572016
Not yet available
GlaxoSmithKline
Colorectal cancer
Phase 2
ABT-510
Not yet available
Abbott Laboratories
Colorectal cancer
Phase 2 planned
ABX-EGF
Not yet available
Abgenix
Renal cancer
Phase 2
Adenoviral p53 (INGN 201)
Not yet available
Introgen Therapeutics
Esophageal squamous cell carcinoma
Phase 1/2
ALVAC-CEA/B7.1
Not yet available ...
[366]
Has Progress Been Made in Gastrointestinal Cancer Treatment?
[23,7 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
SEPTEMBER 2003 |
Hem/Onc today
24
GASTROINTESTINAL CANCER DRUGS IN THE PIPELINE
Information for this chart was gathered from the Pharmaceutical Research and Manufacturers of America, corporate Web sites, meeting abstracts,
and the databases of H
EM
/O
NC
T
ODAY
. The publisher or editors do not assume responsibility for any errors or omissions.
Generic Product
Company
Indication
Phase
572016
Not yet available
GlaxoSmithKline
Colorectal cancer
Phase 2
ABT-510
Not yet available
Abbott Laboratories
Colorectal cancer
Phase 2 planned
ABX-EGF
Not yet available
Abgenix
Renal cancer
Phase 2
Adenoviral p53 (INGN 201)
Not yet available
Introgen Therapeutics
Esophageal squamous cell carcinoma
Phase 1/2
ALVAC-CEA/B7.1
Not yet available ...
[367]
Carcinomatosis from gastrointestinal cancer
[21,2 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
SEPTEMBER 2003 |
Hem/Onc today
24
GASTROINTESTINAL CANCER DRUGS IN THE PIPELINE
Information for this chart was gathered from the Pharmaceutical Research and Manufacturers of America, corporate Web sites, meeting abstracts,
and the databases of H
EM
/O
NC
T
ODAY
. The publisher or editors do not assume responsibility for any errors or omissions.
Generic Product
Company
Indication
Phase
572016
Not yet available
GlaxoSmithKline
Colorectal cancer
Phase 2
ABT-510
Not yet available
Abbott Laboratories
Colorectal cancer
Phase 2 planned
ABX-EGF
Not yet available
Abgenix
Renal cancer
Phase 2
Adenoviral p53 (INGN 201)
Not yet available
Introgen Therapeutics
Esophageal squamous cell carcinoma
Phase 1/2
ALVAC-CEA/B7.1
Not yet available ...
[368]
Alcohol and upper gastrointestinal tract cancer: the role of local ...
[20,2 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
SEPTEMBER 2003 |
Hem/Onc today
24
GASTROINTESTINAL CANCER DRUGS IN THE PIPELINE
Information for this chart was gathered from the Pharmaceutical Research and Manufacturers of America, corporate Web sites, meeting abstracts,
and the databases of H
EM
/O
NC
T
ODAY
. The publisher or editors do not assume responsibility for any errors or omissions.
Generic Product
Company
Indication
Phase
572016
Not yet available
GlaxoSmithKline
Colorectal cancer
Phase 2
ABT-510
Not yet available
Abbott Laboratories
Colorectal cancer
Phase 2 planned
ABX-EGF
Not yet available
Abgenix
Renal cancer
Phase 2
Adenoviral p53 (INGN 201)
Not yet available
Introgen Therapeutics
Esophageal squamous cell carcinoma
Phase 1/2
ALVAC-CEA/B7.1
Not yet available ...
[369]
WORLD SURGERY Grey Turner Memorial Lecture. Progress in ...
[15,7 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
SEPTEMBER 2003 |
Hem/Onc today
24
GASTROINTESTINAL CANCER DRUGS IN THE PIPELINE
Information for this chart was gathered from the Pharmaceutical Research and Manufacturers of America, corporate Web sites, meeting abstracts,
and the databases of H
EM
/O
NC
T
ODAY
. The publisher or editors do not assume responsibility for any errors or omissions.
Generic Product
Company
Indication
Phase
572016
Not yet available
GlaxoSmithKline
Colorectal cancer
Phase 2
ABT-510
Not yet available
Abbott Laboratories
Colorectal cancer
Phase 2 planned
ABX-EGF
Not yet available
Abgenix
Renal cancer
Phase 2
Adenoviral p53 (INGN 201)
Not yet available
Introgen Therapeutics
Esophageal squamous cell carcinoma
Phase 1/2
ALVAC-CEA/B7.1
Not yet available ...
[370]
Gene therapy and gastrointestinal cancer: concepts and clinical ...
[18,8 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
SEPTEMBER 2003 |
Hem/Onc today
24
GASTROINTESTINAL CANCER DRUGS IN THE PIPELINE
Information for this chart was gathered from the Pharmaceutical Research and Manufacturers of America, corporate Web sites, meeting abstracts,
and the databases of H
EM
/O
NC
T
ODAY
. The publisher or editors do not assume responsibility for any errors or omissions.
Generic Product
Company
Indication
Phase
572016
Not yet available
GlaxoSmithKline
Colorectal cancer
Phase 2
ABT-510
Not yet available
Abbott Laboratories
Colorectal cancer
Phase 2 planned
ABX-EGF
Not yet available
Abgenix
Renal cancer
Phase 2
Adenoviral p53 (INGN 201)
Not yet available
Introgen Therapeutics
Esophageal squamous cell carcinoma
Phase 1/2
ALVAC-CEA/B7.1
Not yet available ...
[371]
Factors involved in gastrointestinal bleeding in advanced cancer ...
[19,2 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
SEPTEMBER 2003 |
Hem/Onc today
24
GASTROINTESTINAL CANCER DRUGS IN THE PIPELINE
Information for this chart was gathered from the Pharmaceutical Research and Manufacturers of America, corporate Web sites, meeting abstracts,
and the databases of H
EM
/O
NC
T
ODAY
. The publisher or editors do not assume responsibility for any errors or omissions.
Generic Product
Company
Indication
Phase
572016
Not yet available
GlaxoSmithKline
Colorectal cancer
Phase 2
ABT-510
Not yet available
Abbott Laboratories
Colorectal cancer
Phase 2 planned
ABX-EGF
Not yet available
Abgenix
Renal cancer
Phase 2
Adenoviral p53 (INGN 201)
Not yet available
Introgen Therapeutics
Esophageal squamous cell carcinoma
Phase 1/2
ALVAC-CEA/B7.1
Not yet available ...
[372]
The gastrointestinal symptoms of advanced cancer
[16,4 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
SEPTEMBER 2003 |
Hem/Onc today
24
GASTROINTESTINAL CANCER DRUGS IN THE PIPELINE
Information for this chart was gathered from the Pharmaceutical Research and Manufacturers of America, corporate Web sites, meeting abstracts,
and the databases of H
EM
/O
NC
T
ODAY
. The publisher or editors do not assume responsibility for any errors or omissions.
Generic Product
Company
Indication
Phase
572016
Not yet available
GlaxoSmithKline
Colorectal cancer
Phase 2
ABT-510
Not yet available
Abbott Laboratories
Colorectal cancer
Phase 2 planned
ABX-EGF
Not yet available
Abgenix
Renal cancer
Phase 2
Adenoviral p53 (INGN 201)
Not yet available
Introgen Therapeutics
Esophageal squamous cell carcinoma
Phase 1/2
ALVAC-CEA/B7.1
Not yet available ...
[373]
Cancer and chemotherapy-related upper gastrointestinal symptoms ...
[17,2 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
SEPTEMBER 2003 |
Hem/Onc today
24
GASTROINTESTINAL CANCER DRUGS IN THE PIPELINE
Information for this chart was gathered from the Pharmaceutical Research and Manufacturers of America, corporate Web sites, meeting abstracts,
and the databases of H
EM
/O
NC
T
ODAY
. The publisher or editors do not assume responsibility for any errors or omissions.
Generic Product
Company
Indication
Phase
572016
Not yet available
GlaxoSmithKline
Colorectal cancer
Phase 2
ABT-510
Not yet available
Abbott Laboratories
Colorectal cancer
Phase 2 planned
ABX-EGF
Not yet available
Abgenix
Renal cancer
Phase 2
Adenoviral p53 (INGN 201)
Not yet available
Introgen Therapeutics
Esophageal squamous cell carcinoma
Phase 1/2
ALVAC-CEA/B7.1
Not yet available ...
Found 373 documents
Page 13 of 13 Pages:
<< < 3 4 5 6 7 8 9 10 11 12 13 > >>
cancers
homepage
last week